Crossmark

Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS)

Crossref DOI link: https://doi.org/10.1007/s10067-024-07151-8

Published Online: 2024-09-28

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Makan, Kavita https://orcid.org/0000-0002-5517-7140
Garrido-Cumbrera, Marco

Du Toit, Riette

Correa-Fernández, José

van Dam, Maranda

Tikly, Mohammed
Funding

Funding for this research was provided by:

Novartis Pharma AG, South Africa

University of the Witwatersrand
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Received: 11 April 2024

Revised: 16 September 2024

Accepted: 18 September 2024

First Online: 28 September 2024

Declarations

:

: MGC has received research support from Novartis. KM, RDT, JCF, MVD, and MT have no conflicts of interests to disclose.

Document is current

Any future updates will be listed below